Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego R Falci

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The Lancet. Global Health|December 20, 2024
Improving access to liposomal amphotericin B worldwideAntonio Flores, Diego R Falci
The New England Journal of Medicine|March 29, 2020
Clinical Characteristics of Covid-19 in ChinaAlexandre P Zavascki, Diego R Falci
Mycopathologia|July 1, 2016
Has Aspergillus PCR Come to the Age of Maturity?Alessandro C Pasqualotto, Diego R Falci
Mycoses|January 8, 2019
Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilitiesDiego R Falci, Alessandro C Pasqualotto
Infection and Drug Resistance|November 5, 2013
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infectionsDiego R Falci, Alessandro C Pasqualotto
The New England Journal of Medicine|August 8, 2022
Single-Dose Amphotericin B for Cryptococcal MeningitisDiego R Falci, Alessandro C Pasqualotto
Advances in Experimental Medicine and Biology|August 1, 2019
Clinical Use of Polymyxin BMaria Helena Rigatto, Diego R Falci, Alexandre P Zavascki
Leukemia & Lymphoma|January 29, 2015
Hematological toxicities associated with amphotericin B formulationsDiego R Falci, Franciane B da Rosa, Alessandro C Pasqualotto
Lancet Regional Health. Americas|February 13, 2023
The era of histoplasmosis in Brazilian endemic mycosesDiego R Falci, Daiane F Dalla Lana, Alessandro C Pasqualotto
Mycoses|January 16, 2015
Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life studyDiego R Falci, Franciane B da Rosa, Alessandro C Pasqualotto
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The Lancet. Global Health|December 20, 2024
Improving access to liposomal amphotericin B worldwideAntonio Flores, Diego R Falci
The New England Journal of Medicine|March 29, 2020
Clinical Characteristics of Covid-19 in ChinaAlexandre P Zavascki, Diego R Falci
Mycopathologia|July 1, 2016
Has Aspergillus PCR Come to the Age of Maturity?Alessandro C Pasqualotto, Diego R Falci
Mycoses|January 8, 2019
Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilitiesDiego R Falci, Alessandro C Pasqualotto
Infection and Drug Resistance|November 5, 2013
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infectionsDiego R Falci, Alessandro C Pasqualotto
The New England Journal of Medicine|August 8, 2022
Single-Dose Amphotericin B for Cryptococcal MeningitisDiego R Falci, Alessandro C Pasqualotto
Advances in Experimental Medicine and Biology|August 1, 2019
Clinical Use of Polymyxin BMaria Helena Rigatto, Diego R Falci, Alexandre P Zavascki
Leukemia & Lymphoma|January 29, 2015
Hematological toxicities associated with amphotericin B formulationsDiego R Falci, Franciane B da Rosa, Alessandro C Pasqualotto
Lancet Regional Health. Americas|February 13, 2023
The era of histoplasmosis in Brazilian endemic mycosesDiego R Falci, Daiane F Dalla Lana, Alessandro C Pasqualotto
Mycoses|January 16, 2015
Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life studyDiego R Falci, Franciane B da Rosa, Alessandro C Pasqualotto
Pageof 7